首页> 外文期刊>Military Medicine: Official Journal of AMSUS, The Society of the Federal Health Agencies >Review of new topical hemostatic dressings for combat casualty care.
【24h】

Review of new topical hemostatic dressings for combat casualty care.

机译:回顾用于战斗伤员护理的新型局部止血敷料。

获取原文
获取原文并翻译 | 示例
           

摘要

This review analyzes the new (2008-2013) hemostatic agents and dressings for enhanced efficacy in preclinical studies, and investigates supportive findings among case reports of effectiveness and safety in hospital and prehospital literature. A literature search was conducted using PubMed, National Library of Medicine using key words and phrases. The search revealed a total of 16 articles that fit the criteria established for third-generation hemostatic dressings. There were a total of 9 preclinical, 5 clinical, and 2 prehospital studies evaluated. Evaluation of these third-generation studies reveals that mucoadhesive (chitosan) dressings, particularly Celox Gauze and ChitoGauze, clearly show equal efficacy to Combat Gauze across many dependent variables. Chitosan-based products are ideal prehospital dressings because they are shown to work independently from the physiological clotting mechanisms. Many first-, second-, and third-generation chitosan-based dressings have been in use for years by the United States and other NATO militaries at the point of injury, and during tactical evacuation, in Operation Enduring Freedom and Operation Iraqi Freedom without reported complications or side effects. Based on the reported efficacy and long-term safety of chitosan-based products, increased use of Celox Gauze and ChitoGauze within the Department of Defense and civilian venues merits further consideration and open debate.
机译:这篇综述分析了新的(2008-2013年)止血剂和敷料在临床前研究中的功效,并调查了医院和院前文献中有关有效性和安全性的病例报告中的支持性结果。使用国家医学图书馆PubMed使用关键词和短语进行文献检索。搜索显示共有16篇文章符合第三代止血敷料的标准。总共评估了9项临床前研究,5项临床研究和2项院前研究。对这些第三代研究的评估表明,粘膜粘附性(壳聚糖)敷料,特别是Celox纱布和ChitoGauze,在许多因变量上均清楚显示出与Combat Gauze相同的功效。基于壳聚糖的产品是理想的院前敷料,因为它们显示出与生理凝结机制无关的作用。美国和其他北约军队在受伤时以及战术撤离期间,许多第一代,第二代和第三代基于壳聚糖的敷料已经使用了多年,没有报道。并发症或副作用。基于已报道的基于壳聚糖的产品的功效和长期安全性,国防部和民用场所内Celox纱布和ChitoGauze的使用量增加,值得进一步考虑和公开辩论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号